LSL Pharma Group Inc. (TSXV:LSL)

Canada flag Canada · Delayed Price · Currency is CAD
0.3600
0.00 (0.00%)
Jul 21, 2026, 10:03 AM EST
Market Cap45.62M -8.2%
Revenue (ttm)28.74M +62.0%
Net Income-2.82M
EPS-0.02
Shares Out 126.73M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open0.3650
Previous Close0.3600
Day's Range0.3600 - 0.3650
52-Week Range0.3000 - 0.5600
Beta-0.47
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About LSL Pharma Group

LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. The company offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, and natural health products in liquid and semi-solid form for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada. [Read more]

Sector Healthcare
CEO Francois Roberge
Employees 245
Stock Exchange TSX Venture Exchange
Ticker Symbol LSL
Full Company Profile

Financial Performance

Financial Statements